We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+22.9%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$1.54B
AUM Growth
+$381M
(+33%)
Cap. Flow
+$151M
Cap. Flow
% of AUM
9.83%
Top 10 Holdings %
Top 10 Hldgs %
42.85%
Holding
66
New
16
Increased
21
Reduced
18
Closed
6
Top Buys
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$31.5M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$26.7M |
| 3 |
Regenxbio
RGNX
|
+$24.5M |
| 4 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
+$23.6M |
| 5 |
ICU Medical
ICUI
|
+$23.5M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$51.5M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$47.7M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
+$41M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$39.4M |
| 5 |
Centene
CNC
|
+$29.2M |
Sector Composition
| 1 | Healthcare | 93.1% |
| 2 | Financials | 0.93% |
| 3 | Communication Services | 0.56% |
| 4 | Technology | 0% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $114M | 7.41% |
12,765,862
-3,852,914
| -23% | -$41M |
|
2
Penumbra
PEN
$12.5B
| $86.3M | 5.6% |
1,034,408
-5,800
| -0.6% | -$439K |
|
|
FOLD
3
DELISTED
Amicus Therapeutics
FOLD
| $81.1M | 5.26% |
11,375,852
-955,278
| -8% | -$6.04M |
|
4
Puma Biotechnology
PBYI
$425M
| $64.2M | 4.17% |
1,725,414
+435,274
| +34% | +$15.9M |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $61.9M | 4.02% |
972,696
-647,659
| -40% | -$39.4M |
|
6
Atara Biotherapeutics
ATRA
$76.3M
| $56.2M | 3.65% |
109,365
+2,527
| +2% | +$1.05M |
|
7
Agios Pharmaceuticals
AGIO
$2.36B
| $52.7M | 3.42% |
902,578
+164,127
| +22% | +$7.87M |
|
8
Molina Healthcare
MOH
$12.1B
| $52.4M | 3.4% |
1,149,727
+344,181
| +43% | +$18M |
|
9
Prothena Corp
PRTA
$448M
| $47.4M | 3.08% |
849,483
+195,758
| +30% | +$10.3M |
|
|
SGEN
10
DELISTED
Seagen Inc. Common Stock
SGEN
| $43.8M | 2.84% |
696,386
-824,518
| -54% | -$51.5M |
|
11
Incyte
INCY
$23B
| $41.1M | 2.67% |
307,723
-144,264
| -32% | -$18.4M |
|
|
GWPH
12
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $40.2M | 2.61% |
332,544
-33,524
| -9% | -$4.11M |
|
|
ALDR
13
DELISTED
Alder Biopharmaceuticals
ALDR
| $39.7M | 2.58% |
1,909,886
+989,336
| +107% | +$21.9M |
|
14
Xencor
XNCR
$1.1B
| $38.1M | 2.47% |
1,592,526
+596,426
| +60% | +$14.4M |
|
15
Wave Life Sciences
WVE
$1.14B
| $35M | 2.27% |
1,271,097
+319,385
| +34% | +$8.92M |
|
|
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $34.4M | 2.23% |
934,343
+617,943
| +195% | +$15.6M |
|
|
OXFD
17
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $31.1M | 2.02% |
2,004,849
+303,800
| +18% | +$4.34M |
|
18
Boston Scientific
BSX
$64.6B
| $29.8M | 1.94% |
1,200,099
+740,594
| +161% | +$18M |
|
|
SYNH
19
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $29.1M | 1.89% |
+633,779
| New | +$31.5M |
|
20
Elevance Health
ELV
$84.6B
| $29M | 1.88% |
175,328
+98,105
| +127% | +$15.6M |
|
|
CMRX
21
DELISTED
Chimerix, Inc.
CMRX
| $27.6M | 1.79% |
4,325,055
+979,096
| +29% | +$5.55M |
|
|
22
Neurocrine Biosciences
NBIX
$17.4B
| $26.9M | 1.75% |
+622,345
| New | +$26.7M |
|
|
NDRM
23
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $24.5M | 1.59% |
924,304
-636,515
| -41% | -$15.8M |
|
|
24
ICU Medical
ICUI
$4B
| $24.5M | 1.59% |
+160,543
| New | +$23.5M |
|
|
25
Regenxbio
RGNX
$622M
| $24.5M | 1.59% |
+1,269,131
| New | +$24.5M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO